영상 유도 방사선 치료 시스템 시장 : 시장 예측(2026-2032년)

The Image Guided Radiation Therapy System Market is projected to grow by USD 6.38 billion at a CAGR of 9.40% by 2032.

Image-Guided Radiation Therapy Systems: Executive Overview

Image-guided radiation therapy (IGRT) systems combine radiation treatment with imaging before or during delivery to improve target localization, account for patient movement, and support more precise treatment execution. Their clinical relevance is shaped by the need to balance tumor control with protection of nearby healthy tissue, especially in anatomically complex treatment sites. Adoption depends on oncology infrastructure, staffing, reimbursement, workflow integration, and evidence that imaging and adaptive capabilities improve clinical decision-making.

How Precision Oncology Is Reshaping IGRT Workflows

Radiation oncology is shifting from fixed treatment plans toward image-informed workflows that can verify anatomy, manage motion, and support adaptive decision-making. This transformation increases the importance of interoperable imaging, treatment-planning software, quality assurance, and clinician training. Hospitals are also weighing faster throughput and reduced setup uncertainty against longer procedure times, equipment complexity, radiation exposure from imaging, and the need for robust commissioning and maintenance programs.

Artificial Intelligence Extends Imaging, Planning, and Quality Assurance

Artificial intelligence is increasingly relevant to IGRT through automated image registration, segmentation, motion assessment, contour propagation, treatment adaptation, and anomaly detection. Its practical value depends on representative clinical data, transparent validation, workflow compatibility, cybersecurity, and appropriate human oversight. AI can reduce repetitive tasks and support consistency, but it does not eliminate the need for physicist review, clinician accountability, model monitoring, and safeguards against performance degradation across disease sites, scanners, and patient populations.

Regional IGRT Priorities Across Established and Developing Care Systems

North America generally emphasizes advanced image guidance, adaptive workflows, interoperability, and evidence-based quality programs, while Latin America faces greater variation in equipment access, financing, and specialist availability. Europe is influenced by coordinated clinical standards, cross-border evidence, and modernization of public oncology infrastructure. The Middle East is developing specialized cancer centers alongside workforce and procurement challenges; Africa requires scalable solutions, reliable service support, and stronger referral and training networks. Asia-Pacific combines highly advanced systems in some markets with substantial access and affordability gaps in others, making local infrastructure and implementation models decisive.

What ASEAN, BRICS, EU, G7, GCC, and NATO Contexts Reveal

ASEAN priorities center on expanding oncology capacity while managing uneven infrastructure, training, and reimbursement conditions. BRICS economies show a broad mix of advanced urban centers and under-resourced regions, creating demand for differentiated deployment and service models. European Union settings benefit from common regulatory and clinical frameworks but retain national differences in procurement and access. G7 systems typically focus on modernization, workforce productivity, and integration with mature cancer pathways. GCC countries are investing in specialized care capacity, whereas NATO members may additionally emphasize resilient medical infrastructure, supply continuity, and cybersecurity for connected clinical systems.

Country-Level Signals Shaping IGRT Adoption

Australia and Canada must address geographic dispersion and concentration of specialist services. Brazil, Mexico, India, and South Africa face uneven access between major cities and broader populations, making financing, referral networks, and workforce development central. China, Japan, and South Korea combine strong technical capabilities with differing procurement, regulatory, and hospital-planning environments. France, Germany, Italy, Spain, and the United Kingdom continue to balance clinical modernization with public-system budget discipline and staffing constraints. The United States places strong emphasis on technology integration, clinical productivity, and evidence-supported reimbursement. Russia's priorities include equipment access, domestic capability, service continuity, and regional disparities.

Practical Priorities for Leaders Building Sustainable IGRT Programs

Industry leaders should begin with clearly defined clinical use cases and measurable workflow outcomes rather than technology acquisition alone. They should assess imaging dose, setup accuracy, treatment time, adaptive capacity, interoperability, cybersecurity, service coverage, and total operating requirements during procurement. Implementation plans should include multidisciplinary training, standardized quality assurance, patient-selection criteria, and structured evaluation of clinical and operational results. Partnerships with hospitals, professional societies, and training institutions can strengthen evidence generation and workforce readiness, while modular architectures and dependable remote support can improve resilience across sites with different levels of technical maturity.

Methodology for a Data-Grounded IGRT Executive Summary

This executive summary uses a structured qualitative synthesis of the supplied market definition-image-guided radiation therapy systems-together with established healthcare technology considerations covering clinical workflows, infrastructure, regulation, workforce, reimbursement, interoperability, and artificial intelligence. Geographic interpretation follows the required regional, group, and country classifications. The analysis intentionally excludes market estimates, market shares, forecasts, and company-specific claims, and presents only broadly verifiable sector dynamics rather than unsupported numerical conclusions.

IGRT's Strategic Role in More Adaptive Radiation Care

Image-guided radiation therapy is becoming an important foundation for precise, accountable, and increasingly adaptive radiation oncology. Successful adoption will depend less on imaging capability in isolation than on the alignment of clinical evidence, workflow design, skilled personnel, digital integration, quality assurance, and sustainable service models. Organizations that connect these elements can improve the consistency and responsiveness of treatment delivery while managing the operational, safety, and equity challenges that accompany increasingly complex radiation systems.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Image Guided Radiation Therapy System Market, by Component

• 7.1. Introduction
• 7.2. Hardware
  • 7.2.1. Imaging Systems
  • 7.2.2. Patient Positioning Systems
  • 7.2.3. Radiation Delivery Systems
• 7.3. Services
  • 7.3.1. Consulting Services
  • 7.3.2. Installation Services
  • 7.3.3. Maintenance Services
  • 7.3.4. Training Services
• 7.4. Software
  • 7.4.1. Image Guidance Software
  • 7.4.2. Treatment Planning Software
  • 7.4.3. Workflow Management Software

8. Image Guided Radiation Therapy System Market, by Technology

• 8.1. Introduction
• 8.2. Ct Based
  • 8.2.1. Cone Beam CT
  • 8.2.2. Fan Beam CT
• 8.3. Mri Based
  • 8.3.1. Closed Mri Systems
  • 8.3.2. Open Mri Systems
• 8.4. Ultrasound Based
  • 8.4.1. 2D Ultrasound
  • 8.4.2. 3D Ultrasound
• 8.5. X Ray Based
  • 8.5.1. 2D Planar Imaging
  • 8.5.2. Digital Radiography

9. Image Guided Radiation Therapy System Market, by Deployment

• 9.1. Introduction
• 9.2. Cloud
• 9.3. On Premise

10. Image Guided Radiation Therapy System Market, by Application

• 10.1. Introduction
• 10.2. Brain Cancer
  • 10.2.1. Glioblastoma
  • 10.2.2. Meningioma
• 10.3. Breast Cancer
  • 10.3.1. Early Stage
  • 10.3.2. Metastatic
• 10.4. Colorectal Cancer
• 10.5. Lung Cancer
  • 10.5.1. Non Small Cell Lung Cancer
  • 10.5.2. Small Cell Lung Cancer
• 10.6. Prostate Cancer
  • 10.6.1. Advanced Treatment
  • 10.6.2. Localized Treatment

11. Image Guided Radiation Therapy System Market, by End User

• 11.1. Introduction
• 11.2. Academic Research Institutes
• 11.3. Ambulatory Surgical Centers
• 11.4. Cancer Clinics
• 11.5. Hospitals

12. Image Guided Radiation Therapy System Market, by Region

• 12.1. Introduction
• 12.2. Asia-Pacific
• 12.3. North America
• 12.4. Latin America
• 12.5. Europe
• 12.6. Middle East
• 12.7. Africa

13. Image Guided Radiation Therapy System Market, by Group

• 13.1. Introduction
• 13.2. ASEAN
• 13.3. GCC
• 13.4. European Union
• 13.5. BRICS
• 13.6. G7
• 13.7. NATO

14. Image Guided Radiation Therapy System Market, by Country

• 14.1. Introduction
• 14.2. United States
• 14.3. Canada
• 14.4. Mexico
• 14.5. Brazil
• 14.6. United Kingdom
• 14.7. Germany
• 14.8. France
• 14.9. Russia
• 14.10. Italy
• 14.11. Spain
• 14.12. China
• 14.13. India
• 14.14. Japan
• 14.15. Australia
• 14.16. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. Market Concentration Analysis, 2025
  • 15.2.1. Concentration Ratio (CR)
  • 15.2.2. Herfindahl Hirschman Index (HHI)
• 15.3. Recent Developments & Impact Analysis, 2025
• 15.4. Product Portfolio Analysis, 2025
• 15.5. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Accuray Incorporated
• 16.2. Brainlab AG
• 16.3. Elekta AB
• 16.4. Ion Beam Applications S.A.
• 16.5. RaySearch Laboratories AB
• 16.6. Siemens Healthineers AG
• 16.7. Varian Medical Systems, Inc.
• 16.8. ViewRay Inc.

17. Key Experts